Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer CEO says company "aggressively" seeking deals, does not rule out possible tax inversion
First Word Pharma
Tuesday, July 29, 2014 - 5:22pm
tags:
Ian Read, Pfizer, M&A, tax inversions, Pharma CEOs
Amgen 2nd quarter profit rises; announces up to 2,900 job cuts
Yahoo/AP
Tuesday, July 29, 2014 - 4:39pm
tags:
Amgen, earnings, layoffs
Don't get too excited, investors: GSK has no near-term plans for consumer health spinoff
Fierce Pharma
Tuesday, July 29, 2014 - 3:36pm
tags:
GSK, consumer health
Ranbaxy Reports Quarterly Loss on Settlement Provision
Bloomberg
Tuesday, July 29, 2014 - 3:35pm
tags:
Ranbaxy, earnings
Medical Devices and Technology take Wearables to a Whole New Level
Verix.com
Tuesday, July 29, 2014 - 3:34pm
tags:
Google, Apple, Novartis, devices, Wearable Medical Devices Market
Pfizer, Lilly and J&J chip in on $51M seed fund for New York biotechs
Fierce Biotech
Tuesday, July 29, 2014 - 2:33pm
tags:
JNJ, Eli Lilly, Pfizer, biotech
Beyond the Q2 numbers, three big questions for Pfizer
Fierce Pharma
Tuesday, July 29, 2014 - 2:30pm
tags:
Pfizer, R&D, earnings
Merck: No Tax Inversions, We Just Want Bolt-On Deals
WSJ Online
Tuesday, July 29, 2014 - 2:26pm
tags:
Merck, tax inversions, M&A
Galectin Drug is a Fatty Liver Flop
TheStreet.com
Tuesday, July 29, 2014 - 2:20pm
tags:
Galectin, GR-MD-02, non-alcoholic fatty liver disease
'Do Drug Companies Make Drugs, Or Money?'
Forbes
Tuesday, July 29, 2014 - 10:03am
tags:
Big Pharma, profits, R&D
Why are Anoro and Breo slow starters? GSK's new quota-free model, critics say
Yahoo/AP
Tuesday, July 29, 2014 - 9:38am
tags:
GSK, Anoro Ellipta, Breo Ellipta, quotas, drug reps
Despite outcry over cost, breakthrough drug becomes treatment of choice for hepatitis C
Yahoo/AP
Tuesday, July 29, 2014 - 9:35am
tags:
hepatitis C, Sovaldi, Gilead Sciences
IRS collected $1.4B in medtech excise tax payments in 2013
Mass Device
Tuesday, July 29, 2014 - 9:34am
tags:
device tax, IRS, devices
Bard settles more than 500 pelvic mesh complaints
Mass Device
Tuesday, July 29, 2014 - 9:33am
tags:
CR Bard, pelvic mesh, devices
FDA Performs Inspection of Impax's Taiwan Facility
Yahoo
Tuesday, July 29, 2014 - 9:28am
tags:
FDA, Taiwan, Impax Labs
Pfizer Beats Estimates on Income as Drug Sales Decline
Bloomberg
Tuesday, July 29, 2014 - 9:27am
tags:
Pfizer, earnings
Merck Q2 profit tops estimates on strong consumer sales
Yahoo/Reuters
Tuesday, July 29, 2014 - 9:26am
tags:
Merck, earnings
AcelRx shares plunge after FDA rejects its pain drug/device system
Fierce Biotech
Monday, July 28, 2014 - 4:50pm
tags:
FDA, devices, AcelRx, painkillers, Zalviso
Pfizer, Merck, Amgen Near Q2 Earnings Reports
Investors.com
Monday, July 28, 2014 - 1:31pm
tags:
earnings, Pfizer, Merck, Amgen
FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
Marketwatch
Monday, July 28, 2014 - 1:28pm
tags:
FDA, Imbruvica, chronic lymphocytic leukemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.